id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-310901-oooat8xj	Arca, Karissa N.	COVID‐19 and Headache Medicine: A Narrative Review of Non‐Steroidal Anti‐Inflammatory Drug (NSAID) and Corticosteroid Use	2020-07-10		.txt	text/plain	4428	286	46	Several health organizations have concluded that treatment with corticosteroids during active infection should be avoided due to concerns of prolonged viral shedding in the respiratory tract and the lack of survival benefit based on the data from past coronaviruses and influenza virus; specific exceptions exist including treatment for underlying asthma or chronic obstructive pulmonary disease, septic shock, and acute respiratory distress syndrome. It is recommended that prior to prescribing non‐steroidal anti‐inflammatory drugs and steroids for the treatment of headache, clinicians have open discussions with their patients about the potential risks and benefits of using these medications during the COVID‐19 pandemic. Non-steroidal anti-inflammatory drug (NSAID) and corticosteroid use in patients during the COVID-19 pandemic has been controversial, 6, 7 with existing evidence indirectly suggesting potential benefits 7, 8 or harms, 6, 9 and international and national health organizations providing inconsistent guidance.	./cache/cord-310901-oooat8xj.txt	./txt/cord-310901-oooat8xj.txt